News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
221,954 Results
Type
Article (4978)
Company Profile (22)
Press Release (216954)
Section
Business (82179)
Career Advice (461)
Deals (15038)
Drug Delivery (8)
Drug Development (19054)
Employer Resources (30)
FDA (3672)
Job Trends (3896)
News (120071)
Policy (7497)
Tag
Academia (290)
Alliances (14721)
Alzheimer's disease (219)
Approvals (3669)
Bankruptcy (94)
Best Places to Work (2848)
Biotechnology (24)
Breast cancer (37)
Cancer (288)
Career advice (391)
Cell therapy (63)
Clinical research (15754)
Collaboration (92)
Compensation (84)
COVID-19 (295)
C-suite (54)
Data (343)
Diabetes (25)
Diagnostics (2002)
Earnings (40008)
Employer resources (31)
Events (37103)
Executive appointments (148)
FDA (3803)
Funding (107)
Gene therapy (28)
GLP-1 (98)
Government (406)
Healthcare (5002)
Infectious disease (307)
Inflammatory bowel disease (22)
Interviews (53)
IPO (7749)
Job creations (1120)
Job search strategy (360)
Layoffs (95)
Legal (2322)
Lung cancer (29)
Manufacturing (32)
Medical device (3826)
Medtech (3827)
Mergers & acquisitions (7352)
Metabolic disorders (78)
Neuroscience (272)
NextGen Class of 2024 (1671)
Non-profit (725)
Northern California (570)
Obesity (39)
Opinion (28)
People (24208)
Phase I (4703)
Phase II (6843)
Phase III (5439)
Pipeline (269)
Postmarket research (625)
Preclinical (1841)
Press Release (66)
Radiopharmaceuticals (103)
Rare diseases (40)
Real estate (1868)
Regulatory (4994)
Research institute (298)
Resumes & cover letters (68)
Southern California (434)
Startups (1006)
United States (4562)
Vaccines (25)
Date
Last 7 days (171)
Last 30 days (685)
Last 365 days (11014)
2024 (10788)
2023 (13192)
2022 (18660)
2021 (19682)
2020 (18240)
2019 (13207)
2018 (10205)
2017 (10002)
2016 (9156)
2015 (12119)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8798)
2010 (8634)
Location
Africa (182)
Arizona (49)
Asia (11309)
Australia (1565)
California (1173)
Canada (494)
China (34)
Colorado (47)
Connecticut (65)
Europe (24047)
Florida (156)
Georgia (25)
Idaho (23)
Illinois (80)
Indiana (40)
Japan (35)
Kansas (23)
Maine (34)
Maryland (148)
Massachusetts (983)
Michigan (64)
Minnesota (104)
New Jersey (366)
New York (316)
North Carolina (249)
Northern California (570)
Ohio (38)
Pennsylvania (238)
South America (273)
Southern California (434)
Texas (145)
Utah (34)
Washington State (107)
221,954 Results for "seikagaku corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Ferring Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603 (condoliase), in Lumbar Disc Herniation at ASIPP 2024
Ferring Pharmaceuticals and its clinical development partner, Seikagaku Corporation (Seikagaku), today announced the presentation of data looking at the efficacy and safety profile of SI-6603 (generic name: condoliase), an investigational product intended to treat radicular leg pain associated with lumbar disc herniation (LDH).
April 8, 2024
·
9 min read
Drug Development
Ferring Announces Positive Topline Phase 3 Results for SI-6603, an Investigational Treatment for Lumbar Disc Herniation
Ferring Pharmaceuticals announced that its clinical development partner, Seikagaku Corporation, achieved positive topline results for its registrational Phase 3 clinical trial of SI-6603, an investigational treatment for lumbar disc herniation.
May 26, 2023
·
3 min read
Press Releases
Ferring Announces U.S. FDA Advisory Committee Meeting for SI-6603 (condoliase), An Investigational Treatment in Lumbar Disc Herniation
December 2, 2024
·
3 min read
Press Releases
CENTENE CORPORATION ANNOUNCES 2025 GUIDANCE
December 13, 2024
·
12 min read
Deals
Atrion Corporation Enters Into Merger Agreement with Nordson Corporation
Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.
May 28, 2024
·
9 min read
Press Releases
Shimadzu Invests in Sepragen Corporation
November 20, 2024
·
2 min read
Press Releases
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
November 12, 2024
·
15 min read
Press Releases
Aegis Sciences Corporation Announces Updates for NPS Testing
December 10, 2024
·
2 min read
Business
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”) today announced financial results and recent corporate highlights for the first quarter ended March 31, 2024.
May 13, 2024
·
15 min read
Pharm Country
Quest Diagnostics Releases 2023 Corporate Responsibility Report
Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.
June 27, 2024
·
3 min read
1 of 22,196
Next